These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32266064)

  • 1. A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson's disease potential biomarkers.
    Anjo SI; Dos Santos PV; Rosado L; Baltazar G; Baldeiras I; Pires D; Gomes A; Januário C; Castelo-Branco M; Grãos M; Manadas B
    Transl Neurodegener; 2020; 9():11. PubMed ID: 32266064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study.
    Boerger M; Funke S; Leha A; Roser AE; Wuestemann AK; Maass F; Bähr M; Grus F; Lingor P
    Parkinsonism Relat Disord; 2019 Jun; 63():3-9. PubMed ID: 30876839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A translational view of cells' secretome analysis - from untargeted proteomics to potential circulating biomarkers.
    Anjo SI; Manadas B
    Biochimie; 2018 Dec; 155():37-49. PubMed ID: 29782891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
    Posavi M; Diaz-Ortiz M; Liu B; Swanson CR; Skrinak RT; Hernandez-Con P; Amado DA; Fullard M; Rick J; Siderowf A; Weintraub D; McCluskey L; Trojanowski JQ; Dewey RB; Huang X; Chen-Plotkin AS
    PLoS Med; 2019 Oct; 16(10):e1002931. PubMed ID: 31603904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRNA-derived fragments as sex-dependent circulating candidate biomarkers for Parkinson's disease.
    Magee R; Londin E; Rigoutsos I
    Parkinsonism Relat Disord; 2019 Aug; 65():203-209. PubMed ID: 31402278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
    Kang UJ; Goldman JG; Alcalay RN; Xie T; Tuite P; Henchcliffe C; Hogarth P; Amara AW; Frank S; Rudolph A; Casaceli C; Andrews H; Gwinn K; Sutherland M; Kopil C; Vincent L; Frasier M
    Mov Disord; 2016 Jun; 31(6):924-32. PubMed ID: 27113479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
    Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
    Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
    Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NINDS Parkinson's disease biomarkers program.
    Rosenthal LS; Drake D; Alcalay RN; Babcock D; Bowman FD; Chen-Plotkin A; Dawson TM; Dewey RB; German DC; Huang X; Landin B; McAuliffe M; Petyuk VA; Scherzer CR; Hillaire-Clarke CS; Sieber BA; Sutherland M; Tarn C; West A; Vaillancourt D; Zhang J; Gwinn K;
    Mov Disord; 2016 Jun; 31(6):915-23. PubMed ID: 26442452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation.
    Shi M; Movius J; Dator R; Aro P; Zhao Y; Pan C; Lin X; Bammler TK; Stewart T; Zabetian CP; Peskind ER; Hu SC; Quinn JF; Galasko DR; Zhang J
    Mol Cell Proteomics; 2015 Mar; 14(3):544-55. PubMed ID: 25556233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.
    Narasimhan M; Kannan S; Chawade A; Bhattacharjee A; Govekar R
    J Transl Med; 2019 May; 17(1):184. PubMed ID: 31151397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.
    Srivastava G; Singh K; Tiwari MN; Singh MP
    Expert Rev Proteomics; 2010 Feb; 7(1):127-39. PubMed ID: 20121482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson's disease.
    Ohmichi T; Kasai T; Kosaka T; Shikata K; Tatebe H; Ishii R; Shinomoto M; Mizuno T; Tokuda T
    PLoS One; 2018; 13(7):e0201260. PubMed ID: 30044870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal serum concentrations of proteins in Parkinson's disease.
    Goldknopf IL; Bryson JK; Strelets I; Quintero S; Sheta EA; Mosqueda M; Park HR; Appel SH; Shill H; Sabbagh M; Chase B; Kaldjian E; Markopoulou K
    Biochem Biophys Res Commun; 2009 Nov; 389(2):321-7. PubMed ID: 19723509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted discovery and validation of plasma biomarkers of Parkinson's disease.
    Pan C; Zhou Y; Dator R; Ginghina C; Zhao Y; Movius J; Peskind E; Zabetian CP; Quinn J; Galasko D; Stewart T; Shi M; Zhang J
    J Proteome Res; 2014 Nov; 13(11):4535-45. PubMed ID: 24853996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -Omics biomarker identification pipeline for translational medicine.
    Bravo-Merodio L; Williams JA; Gkoutos GV; Acharjee A
    J Transl Med; 2019 May; 17(1):155. PubMed ID: 31088492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
    Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
    J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
    Yalçınkaya N; Haytural H; Bilgiç B; Özdemir Ö; Hanağası H; Küçükali Cİ; Özbek Z; Akcan U; İdrisoğlu HA; Gürvit H; Tüzün E
    Neurosci Lett; 2016 Feb; 615():72-7. PubMed ID: 26806867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in mitochondrial membrane potential in peripheral blood mononuclear cells in Parkinson's Disease: Potential for a novel biomarker.
    Qadri R; Namdeo M; Behari M; Goyal V; Sharma S; Mukhopadhyay AK
    Restor Neurol Neurosci; 2018; 36(6):719-727. PubMed ID: 30282380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.